You have 2 free disease views remaining today. Register for more view, it is 100% free →
endometrium carcinoma in situ
ICD-10 Codes
Related ICD-10:
Description
Endometrial Carcinoma In Situ: A Complex Hyperplastic Glandular Pattern
Endometrial carcinoma in situ, also known as atypical hyperplasia or adenomatous hyperplasia, is a complex hyperplastic glandular pattern in the endometrium. This condition is characterized by an abnormal growth of cells in the endometrium, which has not yet invaded surrounding tissues.
Key Features
- A complex hyperplastic glandular pattern in the endometrium
- Also labeled as atypical hyperplasia or adenomatous hyperplasia
- Often followed by or accompanies definite adenocarcinoma [1]
- May be recognized as “stage 0” if cancer cells are present in the very top layer of the endometrium and have not invaded surrounding tissues [4]
Precursor Lesions
Descriptions of precursor lesions of endometrial clear cell carcinoma (ECCC) are less robust, but research has identified rare precursor lesions of the endometrium, including clear cell and gastrointestinal variants [3].
Importance of Accurate Diagnosis
Accurate diagnosis is crucial in identifying endometrial carcinoma in situ. High-risk HPV detection within tumor tissue by in situ hybridization or other molecular methods is definitive for identification of high-grade cervical dysplasia and invasive cancer [14].
Additional Characteristics
- A complex hyperplastic glandular pattern in the endometrium
- Atypical hyperplasia or adenomatous hyperplasia
- Often followed by or accompanies definite adenocarcinoma
- May be recognized as âstage 0â if cancer cells are present in the very top layer of the endometrium and have not invaded surrounding tissues
- Clear cell and gastrointestinal variants
Signs and Symptoms
Common Signs and Symptoms
Endometrial carcinoma in situ, also known as atypical hyperplasia or complex hyperplastic glandular pattern, is a precancerous condition that can progress to endometrial cancer if left untreated. The following are common signs and symptoms associated with this condition:
- Irregular vaginal bleeding: This is the most common presenting sign of endometrial carcinoma in situ, occurring early in the disease process [6].
- Abnormal uterine bleeding: Endometrial cancer usually manifests with abnormal uterine bleeding, which should be suspected in any postmenopausal woman with bleeding [5].
- Unusual vaginal discharge or spotting: Some women may experience unusual vaginal discharge or spotting, although this is less common than irregular vaginal bleeding.
- Pain during urination: Pain during urination can occur due to the tumor pressing on surrounding structures.
- Pain during sexual intercourse: Women with endometrial carcinoma in situ may experience pain during sexual intercourse.
Other Possible Signs and Symptoms
In addition to these common signs and symptoms, other possible indicators of endometrial carcinoma in situ include:
- Unexplained weight loss
- Anemia
- Persistent cough
- Abdominal or pelvic pain
It's essential for women experiencing any of these symptoms to consult a healthcare provider for proper evaluation and diagnosis. Early detection and treatment can significantly improve outcomes.
References: [5] Connor E. Signs and Symptoms. Endometrial cancer usually manifests with abnormal uterine bleeding. It should be suspected in any postmenopausal woman with bleeding. [6] Oct 21, 2024 — Irregular vaginal bleeding is the most common presenting sign of endometrial cancer.
Additional Symptoms
- Persistent cough
- Abdominal or pelvic pain
- Abnormal uterine bleeding
- Irregular vaginal bleeding
- weight loss
- anemia
- vaginal discharge
- pain
Diagnostic Tests
Diagnostic Tests for Endometrial Carcinoma in Situ
Endometrial carcinoma in situ, also known as endometrial hyperplasia with atypia, is a precancerous condition where the cells lining the uterus grow abnormally. Early detection and diagnosis are crucial to prevent progression to invasive cancer.
- Transvaginal Ultrasound (TVUS): This imaging test can detect abnormalities in the uterine lining, such as thickening or masses, which may indicate endometrial carcinoma in situ [1].
- Fluorescence In Situ Hybridization (FISH) Test: A non-invasive vaginal swab test that detects genetic changes associated with endometrial cancer cells [2].
- Endometrial Biopsy: A procedure where a sample of tissue is taken from the uterine lining to examine for abnormal cell growth. This is considered an accurate method for diagnosing endometrial carcinoma in situ, especially when an adequate specimen is obtained [3].
- Pap Test and Blood Tests: While not specific for endometrial cancer, these tests can show whether cancer cells have spread to the cervix or indicate liver and kidney function problems [4][5].
Other Diagnostic Methods
- Hysteroscopy: A diagnostic test where a flexible tube is inserted into the uterus to examine the uterine lining. This may be performed to rule out other conditions, such as polyps or fibroids [6].
- Glandular Crowding and Cytology: The diagnostic criteria for Endometrial Intestinal Neoplasia (EIN) include glandular crowding and cytological differences between the crowded focus and background. These features may be observed in endometrial carcinoma in situ [7].
Specialized Care
- Gynecologists and Gynecologic Oncologists: Trained doctors who can diagnose and treat diseases of the female reproductive system, including endometrial cancer. They may also provide guidance on treatment options [8].
- Clinical Trials: Research studies that explore new treatments, interventions, and tests for endometrial cancer. These trials may offer opportunities to participate in innovative care approaches [9].
Stages of Endometrial Cancer
The stage of endometrial cancer is crucial in determining the treatment plan. The stages are determined by examining information from exams and diagnostic tests, including the extent of tumor spread and lymph node involvement [10][11].
Treatment
Differential Diagnosis
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:5172
- core#notation
- DOID:5172
- oboInOwl#hasDbXref
- UMLS_CUI:C0346191
- IAO_0000115
- An in situ carcinoma that is located_in the endometrium.
- oboInOwl#hasExactSynonym
- endometrial carcinoma in situ
- rdf-schema#label
- endometrium carcinoma in situ
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_289
- relatedICD
- http://example.org/icd10/D07.0
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- owl#equivalentClass
- t437106
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_11375
- owl#annotatedSource
- t437573
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.